Bo Shen, Chun Wang, Liqin Zhang, Yingying Zhu, Xing Zhang, Xiaoxuan Wang, Zhen Guo, Li Wang, Xiaohua Wang, Liqun Zhu, Yun Zhou, Danting Liao, Meiqi Shi. "Double-dose firmonertinib as first-line treatment in patients with locally advanced or metastatic non-small-cell lung cancer harboring EGFR L858R mutation: a prospective, multicenter, phase II study (FIRM)." Nature Communications, 2026. doi:10.1038/s41467-026-68554-6